Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model.

A W Nienhuis; R E Donahue; S Karlsson; S C Clark; B Agricola; N Antinoff; J E Pierce; P Turner; W F Anderson; D G Nathan

doi:10.1172/JCI113106

Find articles by Nienhuis, A. in: PubMed | Google Scholar

Find articles by Donahue, R. in: PubMed | Google Scholar

Find articles by Karlsson, S. in: PubMed | Google Scholar

Find articles by Clark, S. in: PubMed | Google Scholar

Find articles by Agricola, B. in: PubMed | Google Scholar

Find articles by Antinoff, N. in: PubMed | Google Scholar

Find articles by Pierce, J. in: PubMed | Google Scholar

Find articles by Turner, P. in: PubMed | Google Scholar

Find articles by Anderson, W. in: PubMed | Google Scholar

Find articles by Nathan, D. in: PubMed | Google Scholar

Published in Volume 80, Issue 2 on August 1, 1987
J Clin Invest. 1987;80(2):573–577. https://doi.org/10.1172/JCI113106.
© 1987 The American Society for Clinical Investigation

Published August 1, 1987 - Version history

The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hematopoietic reconstitution after autologous bone marrow transplantation was evaluated in a primate model. Animals were given a continuous intravenous infusion of recombinant human GM-CSF for several days both before and after transplantation or only after the transplant procedure. Marrow ablation was accomplished by total body irradiation. In both groups of animals, the neutrophil count reached 1,000/mm3 by 8-9 d posttransplant compared with an interval of 17 and 24 d for two concurrent controls. After withdrawal of GM-CSF, neutrophil counts fell to values comparable to those observed in untreated controls. Accelerated recovery of platelet production was also observed in four of the five animals. Two additional animals were initially given GM-CSF several weeks posttransplantation because of inadequate engraftment. Prompt and sustained increases in neutrophil and platelet counts were observed. We conclude that GM-CSF may be useful in accelerating bone marrow reconstitution.

Click on an image below to see the page. View PDF of the complete article